Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Entrada Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +10 vs. Q1 2026
- Shares held
- 29.1M
- +3.61M (+14.2%) vs. Q1 2026
- Total value
- $214.4M
- −$107.0M (−33.3%) vs. Q1 2026
- New holders
- 26
- 55 more added
- Sold out
- 16
- 31 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 128 | $214.4M |
| Q1 2026 | 119 | $321.4M |
| Q4 2025 | 113 | $251.0M |
| Q3 2025 | 116 | $164.8M |
| Q2 2025 | 107 | $198.8M |
| Q1 2025 | 110 | $274.5M |
| Q4 2024 | 102 | $529.8M |
| Q3 2024 | 97 | $481.1M |
| Q2 2024 | 84 | $423.1M |
| Q1 2024 | 77 | $368.8M |
| Q4 2023 | 62 | $396.6M |
| Q3 2023 | 55 | $411.4M |
| Q2 2023 | 56 | $389.9M |
| Q1 2023 | 53 | $361.0M |
| Q4 2022 | 47 | $334.2M |
| Q3 2022 | 33 | $386.4M |
| Q2 2022 | 38 | $301.8M |
| Q1 2022 | 48 | $242.8M |
| Q4 2021 | 46 | $433.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 178,606 | $1.31M | 0.15% | −33,083−15.6% | Reduced |
| Quantinno Capital Management LP | 188,839 | $1.39M | 0.00% | +117,821+165.9% | Added |
| Renaissance Technologies LLC | 191,000 | $1.41M | 0.00% | −11,084−5.5% | Reduced |
| Morgan Stanley | 191,650 | $1.41M | 0.00% | +15,524+8.8% | Added |
| Longaeva Partners L.P. | 195,237 | $1.44M | 0.04% | −9,741−4.8% | Reduced |
| Charles Schwab Investment Management Inc | 197,136 | $1.45M | 0.00% | −17,615−8.2% | Reduced |
| Vanguard Portfolio Management LLC | 254,130 | $1.87M | 0.00% | +33,636+15.3% | Added |
| Nantahala Capital Management, LLC | 300,575 | $2.21M | 0.13% | +141,243+88.6% | Added |
| Jacobs Levy Equity Management, Inc | 303,459 | $2.23M | 0.01% | −30,455−9.1% | Reduced |
| Northern Trust Corp | 309,942 | $2.28M | 0.00% | +74,950+31.9% | Added |
| Dimensional Fund Advisors LP | 376,136 | $2.77M | 0.00% | +51,665+15.9% | Added |
| Citadel Advisors LLC | 394,323 | $2.90M | 0.00% | +179,305+83.4% | Added |
| Acadian Asset Management LLC | 400,862 | $2.94M | 0.00% | +67,693+20.3% | Added |
| JPMorgan Chase & Co | 496,457 | $3.83M | 0.00% | +481,610+3,243.8% | Added |
| Price T Rowe Associates Inc | 542,316 | $3.99M | 0.00% | +16,273+3.1% | Added |
| State Street Corp | 596,677 | $4.39M | 0.00% | +62,879+11.8% | Added |
| AQR Capital Management LLC | 699,537 | $5.15M | 0.00% | +620,044+780.0% | Added |
| Geode Capital Management, LLC | 717,430 | $5.28M | 0.00% | +50,083+7.5% | Added |
| StepStone Group LP | 761,277 | $5.60M | 0.26% | 00.0% | Unchanged |
| Millennium Management LLC | 763,959 | $5.62M | 0.00% | +244,603+47.1% | Added |
| Wellington Management Group LLP | 954,419 | $7.02M | 0.00% | −80,363−7.8% | Reduced |
| TCG Crossover Management, LLC | 1,060,230 | $7.80M | 0.19% | −1,227,270−53.7% | Reduced |
| MPM Oncology Impact Management LP | 1,253,053 | $9.22M | 0.56% | +1,253,053 | New |
| Vanguard Capital Management LLC | 1,269,634 | $9.34M | 0.00% | +13,621+1.1% | Added |
| Merck & Co., Inc. | 1,739,768 | $12.8M | 2.43% | +1,739,768 | New |
| BlackRock, Inc. | 2,583,333 | $19.0M | 0.00% | +224,540+9.5% | Added |
| 5AM Venture Management, LLC | 4,056,379 | $29.9M | 10.37% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 5,072,730 | $37.3M | 0.19% | 00.0% | Unchanged |
| Jones Hill Capital LP | 0 | $0 | 0.00% | −374,010−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −89,358−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −53,764−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −37,213−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −22,230−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −21,548−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,315−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −16,474−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −11,102−100.0% | Sold out |
| IHT Wealth Management, LLC | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −208−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Wealth Preservation Advisors, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |